Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Aug;52(8):1408-17.
doi: 10.1093/rheumatology/kes414. Epub 2013 Jan 30.

Ayurvedic Medicine Offers a Good Alternative to Glucosamine and Celecoxib in the Treatment of Symptomatic Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Equivalence Drug Trial

Affiliations
Randomized Controlled Trial

Ayurvedic Medicine Offers a Good Alternative to Glucosamine and Celecoxib in the Treatment of Symptomatic Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Equivalence Drug Trial

Arvind Chopra et al. Rheumatology (Oxford). .

Abstract

Objective: To demonstrate clinical equivalence between two standardized Ayurveda (India) formulations (SGCG and SGC), glucosamine and celecoxib (NSAID).

Methods: Ayurvedic formulations (extracts of Tinospora cordifolia, Zingiber officinale, Emblica officinalis, Boswellia serrata), glucosamine sulphate (2 g daily) and celecoxib (200 mg daily) were evaluated in a randomized, double-blind, parallel-efficacy, four-arm, multicentre equivalence drug trial of 24 weeks duration. A total of 440 eligible patients suffering from symptomatic knee OA were enrolled and monitored as per protocol. Primary efficacy variables were active body weight-bearing pain (visual analogue scale) and modified WOMAC pain and functional difficulty Likert score (for knee and hip); the corresponding a priori equivalence ranges were ±1.5 cm, ±2.5 and ±8.5.

Results: Differences between the intervention arms for mean changes in primary efficacy variables were within the equivalence range by intent-to-treat and per protocol analysis. Twenty-six patients showed asymptomatic increased serum glutamic pyruvic transaminase (SGPT) with otherwise normal liver function; seven patients (Ayurvedic intervention) were withdrawn and SGPT normalized after stopping the drug. Other adverse events were mild and did not differ by intervention. Overall, 28% of patients withdrew from the study.

Conclusion: In this 6-month controlled study of knee OA, Ayurvedic formulations (especially SGCG) significantly reduced knee pain and improved knee function and were equivalent to glucosamine and celecoxib. The unexpected SGPT rise requires further safety assessment.

Trial registration: Clinical Drug Trial Registry-India, www.ctri.nic.in, CTRI/2008/091/000063.

Keywords: Ayurvedic medicines; analgesics; arthritis; chondroprotective agents; drug trials; equivalence drug trials; ethnic medicine; herbal drugs; non-steroidal anti-inflammatory drugs (NSAIDs); osteoarthritis.

Comment in

Similar articles

See all similar articles

Cited by 25 articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback